Aptose Biosciences Inc.
APTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25 | -$51 | -$42 | -$65 |
| Dep. & Amort. | $0 | $0 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $4 | $5 | $13 |
| Change in WC | -$11 | $2 | $4 | $2 |
| Other Non-Cash | -$1 | $0 | -$1 | $7 |
| Operating Cash Flow | -$36 | -$45 | -$32 | -$43 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$35 |
| Inv. Sales/Matur. | $0 | $10 | $29 | $0 |
| Other Inv. Act. | $0 | $0 | $1 | $0 |
| Investing Cash Flow | $0 | $10 | $30 | -$35 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10 | $0 | $0 | $0 |
| Stock Issued | $23 | $7 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $33 | $7 | $0 | $0 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$3 | -$28 | -$2 | -$78 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9 | $37 | $39 | $117 |
| End Cash | $7 | $9 | $37 | $39 |
| Free Cash Flow | -$36 | -$45 | -$32 | -$44 |